In today’s pharmaceutical landscape, environmental sustainability has moved beyond a competitive edge to become a fundamental expectation. Amidst tightening regulatory frameworks, mounting ESG pressures, and a rapidly evolving digital ecosystem, the pharmaceutical industry finds itself at a critical juncture.
One of the most transformative elements of this shift is the rise of Electronic Batch Records (EBRs). More than a tool for quality assurance or operational efficiency, EBRs are now serving as the digital backbone for sustainability efforts across the sector. But the true power of EBRs is only beginning to emerge with the integration of artificial intelligence (AI), which is redefining what it means to manufacture intelligently, efficiently, and responsibly.
Although the concept of electronic batch records has existed for decades, their adoption has been slow, particularly among contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs). Barriers such as high implementation costs, complex ERP integrations, and the perceived workflow disruption have slowed progress. Yet, as digital maturity grows and AI capabilities become more accessible, companies are beginning to see EBRs not merely as digital repositories, but as engines of sustainability.
The Paper Trail Problem
Historically, batch recordkeeping has been a paperwork-intensive process, with each production run involving extensive documentation including manufacturing instructions, quality control checks, packaging records, deviation logs, training certifications, and more. For large CDMOs this can translate into millions of pages of printed records annually.
This isn’t just a storage or labor problem. According to the Environmental Paper Network, one ton of office paper (about 200,000 sheets) consumes approximately 24 trees, 20,000 gallons of water, and 4,100 kWh of energy to produce. This production emits over 5,690 pounds of CO₂ equivalent when factoring in lifecycle emissions 1.
Applying those figures to a mid-sized pharmaceutical manufacturer using 10 million pages annually, the environmental cost includes the destruction of over 1,200 trees, consumption of a million gallons of water, and the release of more than 250 tons of carbon dioxide into the atmosphere.
For a global enterprise operating across multiple facilities, the impact escalates dramatically. Add to that the emissions associated with transporting physical records, the energy used to store and archive them, and the inevitable waste from misprints and documentation errors, and it becomes clear: traditional batch documentation is environmentally unsustainable.
Enter Electronic Batch Records: Sustainability by Design
EBRs digitise every element of the batch manufacturing process. By eliminating physical paperwork, companies not only reduce their carbon footprint but also enable broader process improvements.
Lori Jackson, PCI’s Sr. Director Global Digital Quality & Program Management states, “PCI’s digital transformation took a major leap forward in 2020 with the implementation of MasterControl’s Qx suite. Since then, we’ve deployed six modules across 14 of our 17 global sites and successfully trained over 7,000 users worldwide. The Qx suite was the foundation for PCI to move forward with EBR.”
Key environmental benefits from this transition include:
- Elimination of Physical Documents: Each batch record, often hundreds of pages long, is now fully digital. For one product run, PCI consolidated 13 paper batch records supporting 120 SKUs into just two digital production records.
- Reduced Shipping and Storage Emissions: By eliminating the need to transport, archive, and retrieve physical documents, PCI minimizes emissions associated with document handling logistics.
- Fewer Reprints and Errors: Digital workflows mean fewer batch failures due to paperwork errors, reducing rework and material waste, which is a notable environmental gain in high-volume manufacturing3.
- Less Hardware Waste: As legacy systems are consolidated, redundant servers, scanners, and printers are phased out, reducing e-waste and power consumption.
Tim Hansen, PCI’s ESG Director adds, “Our commitment to environmental stewardship goes beyond compliance. It’s about building smarter, leaner, and more sustainable systems. Electronic Batch Records eliminate waste at the source and lay the groundwork for advanced tools like AI and predictive analytics that will redefine sustainable manufacturing.”
Industry-Wide Momentum and Metrics
The benefits are not just theoretical. A 2023 survey by Pharmaceutical Manufacturing found that 62 percent of pharma companies now list environmental impact reduction among their top five reasons for adopting EBRs. That’s a sharp increase from 41% in 2020. The survey stated more noteworthy findings, including 67% of companies using EBRs reported a 30-60% reduction in paper use, while 55% saw lower energy consumption associated with documentation processes. Nearly half noted improvements in ESG audit scores directly related to digital recordkeeping2.
Further data from MasterControl shows that clients deploying its EBR systems typically see a 90% reduction in paper usage, a 70% faster resolution time for deviations, and a 40% reduction in waste related to rework3.
These statistics point to a new paradigm: digitization isn’t just an IT upgrade; it’s a business and environmental imperative.
Digital Foundations Enable AI and Optimisation
While EBRs provide the structure and data integrity needed for compliance and efficiency, AI adds the intelligence layer that unlocks continuous improvement. Through the application of machine learning, predictive analytics, and natural language processing, pharmaceutical manufacturers can convert vast repositories of batch data into actionable insights. AI can identify patterns and correlations that would be nearly impossible to detect manually, enabling a shift from reactive to proactive manufacturing.
For example, AI algorithms can analyze digital batch records to detect deviations in real time and even predict potential process failures before they occur. This not only reduces downtime but also minimizes the risk of batch failures, which are notoriously resource intensive. Every failed batch means wasted raw materials, lost production time, and unnecessary energy consumption; all of which contribute to a larger environmental footprint. By catching these issues early, AI helps ensure that manufacturing runs more smoothly and sustainably.
AI also enables optimised material usage. Historical data can inform smarter formulation decisions, helping manufacturers reduce overages, balance inputs more precisely, and minimize solvent and water use. These micro-optimisations, applied consistently across thousands of batches, result in macro-level environmental savings. Moreover, the use of AI to fine-tune manufacturing parameters can improve yield and reduce the frequency of out-of-spec batches, further cutting waste.
In addition to process optimisation, companies like PCI are leveraging AI for operational efficiency in training and global compliance. The company is currently testing AI-powered tools for automated document translation and exam generation, significantly reducing the time and complexity involved in onboarding staff across its global sites in Germany and Spain. These technologies lower the language and training barriers that often slow digital adoption, ensuring more rapid deployment of sustainable practices.
Challenges: Time, Resources, and Culture
Of course, implementing EBR systems and layering AI on top is not without its challenges. Jackson emphasizes that time and resources, rather than resistance to change, are the primary barriers to adoption. For companies navigating frequent mergers and acquisitions, harmonising systems across facilities is particularly complex. PCI has addressed this by avoiding a “big bang” rollout and instead adopting a modular approach, tailoring onboarding checklists and deployment strategies to the unique needs of each site. This phased methodology has proven effective in reducing disruption while still moving the organization steadily toward full digital maturity.
Regulatory and Strategic Alignment
From a regulatory standpoint, the shift toward digital documentation is also gaining traction. Guidelines such as the FDA’s 21 CFR Part 11 and the EMA’s GxP reflection papers strongly advocate for electronic systems that support data integrity, real-time traceability, and audit readiness. EBRs meet these criteria by offering tamper-evident digital trails, time-stamped approvals, and secure storage, reducing the risk of incomplete or lost records.
What’s particularly compelling is how this regulatory alignment dovetails with environmental goals. As pharmaceutical companies face increasing scrutiny from investors, regulators, and consumers alike, tools that enhance both compliance and sustainability offer a rare and valuable convergence of interests. The ability to demonstrate traceable, verifiable environmental responsibility is becoming just as important as showing product quality or regulatory adherence.
Looking Ahead: A Greener Pharma Industry
The integration of EBRs with broader enterprise systems promises even greater impact. PCI envisions a future where EBRs connect seamlessly with ERP platforms, laboratory information management systems (LIMS), and environmental monitoring systems. This kind of connectivity will enable real-time carbon tracking, dynamic resource allocation, and continuous improvement loops driven by AI. Instead of reacting to inefficiencies after the fact, companies will be able to course-correct in real time, reducing their environmental impact with each batch produced.
Jackson summarizes the vision well stating, “We’ve torn down silos. We’re comparing apples to apples across sites, and we’re supporting the client’s needs, and the planet’s, in a much better way.”
Electronic Batch Records are no longer just digitised file cabinets, but are foundational elements of a smarter, more sustainable pharmaceutical manufacturing model. When augmented with artificial intelligence, EBRs become powerful tools for process optimisation, environmental stewardship, and strategic alignment. As companies like PCI lead the way, it’s becoming increasingly clear that the path to a greener industry isn’t paved with paper. It’s driven by data, powered by intelligence, and guided by a deeper commitment to both operational excellence and planetary health.
References:
- Environmental Paper Network. Paper Calculator v4.0. https://c.environmentalpaper.org
- Pharmaceutical Manufacturing Industry Survey, 2023. Pharma Manufacturing Journal.
- MasterControl. Customer Impact Summary & Benchmarking Reports, 2022–2024
We are committed to supporting clients at every stage of the manufacturing cycle, delivering best-in-class services efficiently and effectively.
Find out more about our fully integrated Packaging Services.
